Lithium can work very well for bipolar disorder, but it needs careful blood test monitoring because the useful dose and the harmful dose are close together. A lithium level shows how much lithium is in the blood at the time the sample is taken. Kidney function tests show how well the body is clearing lithium, because lithium leaves the body almost entirely through the kidneys. A safe-looking lithium result can still need attention if the sample was drawn at the wrong time, the dose recently changed, kidney function is worsening, or symptoms suggest toxicity. The most useful interpretation combines the lithium number, timing of the blood draw, dose schedule, symptoms, kidney markers, fluid balance, and interacting medicines. Small changes—such as dehydration, vomiting, diarrhea, a new blood pressure medicine, or regular use of anti-inflammatory pain relievers—can raise lithium levels and increase toxicity risk.
- A lithium level is usually interpreted as a 12-hour trough, meaning the sample is drawn about 12 hours after the last dose and before the next dose.
- For many adults on maintenance treatment, a common lithium target is about 0.6–0.8 mmol/L, with lower or higher targets used in selected situations.
- Lithium toxicity becomes more likely around 1.5 mmol/L and above, but symptoms can occur even when the blood level appears “therapeutic.”
- Kidney monitoring usually includes creatinine, eGFR, urea or BUN, electrolytes, calcium, and urine-related symptoms such as thirst and frequent urination.
- Dehydration, low sodium intake, NSAIDs, ACE inhibitors, ARBs, and thiazide diuretics can raise lithium levels.
- Urgent care is needed for confusion, severe drowsiness, severe tremor, poor coordination, repeated vomiting or diarrhea, seizures, fainting, or suspected overdose.
Table of Contents
- What Lithium Monitoring Measures
- Therapeutic Ranges and Blood Draw Timing
- Kidney Function Results That Change Interpretation
- Lithium and Kidney Test Patterns That Need Attention
- Toxicity Symptoms and Urgent Thresholds
- Medications, Fluid Balance, and Lab Pitfalls
- How Monitoring Usually Changes Over Time
- Questions to Discuss With Your Clinician
What Lithium Monitoring Measures
A lithium level measures the concentration of lithium in the blood, usually reported in mmol/L. In lithium testing, mmol/L and mEq/L are numerically the same because lithium carries a single positive charge. A result of 0.7 mmol/L is therefore the same as 0.7 mEq/L.
Lithium has a narrow therapeutic index. That means the blood concentration that helps stabilize mood is not far below the concentration that can cause harm. This is why lithium is not adjusted only by “how many milligrams” a person takes. Two people can take the same dose and have different blood levels because of kidney function, age, body water, sodium balance, other medicines, dose timing, and adherence.
A lithium blood test is most useful when it is interpreted with the dose schedule. For example, a level drawn 4 hours after a dose can look higher than a true trough level. A level drawn 18 to 24 hours after a dose may look lower. The result also needs context from symptoms. A person with new confusion, poor balance, vomiting, or a coarse tremor needs clinical attention even if the number is not dramatically high.
Kidney function matters because lithium is cleared mainly by the kidneys. The body handles lithium in a way that overlaps with sodium and water handling. When the body tries to conserve sodium and water, it may also retain more lithium. This is one reason dehydration, low salt intake, vomiting, diarrhea, fever, heavy sweating, or certain blood pressure medicines can raise lithium levels.
Therapeutic drug monitoring is the process of checking drug levels to keep treatment effective and safe. Lithium is one of the classic examples. A broader therapeutic drug monitoring panel may include other medicines that also need level-based dosing, but lithium interpretation is especially tied to kidney function and fluid balance.
Therapeutic Ranges and Blood Draw Timing
Lithium ranges are not one-size-fits-all. The target depends on why lithium is being used, how well it controls symptoms, age, side effects, kidney function, relapse history, and whether the person is in an acute mood episode or long-term maintenance treatment.
For many adults taking lithium for maintenance treatment, a common target is about 0.6–0.8 mmol/L. Some people who respond well but have side effects may be managed at about 0.4–0.6 mmol/L. Some people with relapse despite treatment or ongoing impairing symptoms may be managed closer to 0.8–1.0 mmol/L for a period of time, if tolerated and clinically appropriate. Higher ranges may be used in acute mania, but toxicity risk rises as the level increases.
| Result or target | Common meaning | Usual follow-up consideration |
|---|---|---|
| Below about 0.4 mmol/L | Often below the usual maintenance target, though some people may still benefit | Review timing, missed doses, dose changes, symptoms, and treatment plan |
| About 0.4–0.6 mmol/L | May be used for people with good response but side effects, older adults, or higher toxicity risk | Balance relapse prevention against tolerability and kidney risk |
| About 0.6–0.8 mmol/L | Common maintenance range for many adults | Continue routine monitoring if symptoms and kidney results are stable |
| About 0.8–1.0 mmol/L | Sometimes used when symptoms persist or relapse has occurred | Monitor more closely for tremor, stomach symptoms, kidney changes, and interactions |
| About 1.2 mmol/L or higher | Closer to toxicity range, depending on clinical setting and timing | Prompt clinical review is usually needed, especially with symptoms |
| About 1.5 mmol/L or higher | Toxicity becomes much more likely | Urgent medical assessment is often needed, especially with neurologic or gastrointestinal symptoms |
Why the 12-hour trough matters
Lithium levels are usually checked as a trough level. A trough is the lowest concentration before the next dose. For lithium, this is commonly measured about 12 hours after the last dose. If someone takes lithium at 9 p.m., a blood draw around 9 a.m. the next morning often gives the intended 12-hour sample.
Timing errors can change the meaning of the result. A level drawn too soon after a dose may look falsely high compared with the expected trough. A level drawn too late may look falsely low. This can lead to the wrong dose change if the timing is not documented.
The lab request and the clinical note should ideally include:
- Time of the last lithium dose
- Time of the blood draw
- Current daily dose and formulation
- Whether any doses were missed
- Recent vomiting, diarrhea, fever, dehydration, or heavy sweating
- New or changed medicines
- New symptoms such as tremor, poor balance, confusion, thirst, or frequent urination
Why “therapeutic” does not always mean safe
A therapeutic lithium level means the number is within the intended range for many people. It does not prove that the dose is safe for every person at every moment. Chronic toxicity can happen with levels that are not extremely high, especially in older adults, people with kidney disease, or people whose levels rose slowly over time.
Symptoms can matter more than the number. A person with ataxia, confusion, slurred speech, severe tremor, or repeated vomiting needs assessment even if the reported level is near the usual range. Lithium enters and leaves the brain more slowly than it enters and leaves the blood, so symptoms and blood levels do not always move together neatly.
Kidney Function Results That Change Interpretation
Kidney tests help show whether lithium is being cleared normally and whether long-term lithium use may be affecting the kidneys. A kidney function blood test panel often includes creatinine, eGFR, urea or BUN, and electrolytes. Calcium and thyroid tests are also commonly monitored during lithium treatment because lithium can affect parathyroid and thyroid function.
Creatinine is a waste product from muscle metabolism. When kidney filtration falls, creatinine often rises. eGFR, or estimated glomerular filtration rate, estimates kidney filtering capacity using creatinine and patient factors such as age and sex. The creatinine and eGFR pattern is more informative than either number alone.
Urea or BUN can rise with reduced kidney function, dehydration, high protein intake, gastrointestinal bleeding, or catabolic stress. In lithium monitoring, a rising urea or BUN result may point to dehydration or reduced kidney clearance, both of which can increase lithium risk.
Electrolytes are also important. Sodium balance is closely tied to lithium handling. Low sodium intake or sodium loss can lead the kidneys to retain more lithium. Potassium and bicarbonate can reveal broader kidney or acid-base problems, especially when kidney function is impaired or the person is taking other medicines. An electrolyte panel can help place a lithium result in a safer clinical context.
eGFR trends matter more than one isolated value
A single eGFR value can be affected by hydration, muscle mass, lab variation, recent illness, and medications. A trend over time is usually more useful. A gradual decline over months or years may suggest chronic kidney stress. A sudden drop over days or weeks may suggest acute kidney injury, dehydration, infection, medication effect, obstruction, or another new problem.
Lithium dosing often needs closer review when:
- Creatinine rises compared with the person’s usual baseline
- eGFR falls on repeated tests
- Urea or BUN rises along with signs of dehydration
- Urine output changes noticeably
- The person develops marked thirst or frequent urination
- A lithium level rises without an intentional dose increase
- New interacting medicines have been added
Polyuria and polydipsia can point to tubular effects
Lithium can affect the kidney tubules, which help concentrate urine. Some people develop nephrogenic diabetes insipidus, a condition in which the kidneys do not respond normally to antidiuretic hormone. The result is large amounts of dilute urine, frequent urination, nighttime urination, and intense thirst.
This problem is not the same as diabetes mellitus, which involves high blood sugar. In lithium-related nephrogenic diabetes insipidus, glucose may be normal. The concern is water balance. A person who loses too much water in urine can become dehydrated more easily. Dehydration can then raise lithium levels, creating a cycle of worsening symptoms and higher toxicity risk.
Lithium and Kidney Test Patterns That Need Attention
Lithium results are easiest to interpret when grouped into patterns. The same number can mean different things depending on symptoms, kidney function, and timing.
High lithium with stable kidney function
A high lithium level with stable creatinine and eGFR can happen after a dose increase, a blood draw too soon after the last dose, a formulation change, a medication interaction, or accidental extra doses. The first step is usually to confirm timing and dosing history. A repeat properly timed trough may be needed before making a long-term dose decision, unless symptoms require urgent action.
Even with stable kidney function, a high result deserves respect. Lithium toxicity can affect the nervous system, stomach, heart rhythm, and kidneys. The dose should not be adjusted casually without the prescribing clinician’s guidance.
Therapeutic lithium with worsening kidney function
A lithium level in range does not rule out kidney stress. If creatinine is rising or eGFR is falling, the clinician may review the lithium dose, target range, other kidney risks, blood pressure, diabetes status, urine findings, NSAID use, ACE inhibitor or ARB use, diuretic use, and the rate of kidney decline.
This pattern does not automatically mean lithium must be stopped. Lithium may be providing strong protection against relapse, mania, depression, hospitalization, or suicide risk. The decision often weighs psychiatric benefit against kidney risk. In some cases, the target lithium level is lowered, dosing is simplified, interacting drugs are changed, or nephrology input is requested.
Normal lithium with toxicity symptoms
Symptoms can occur even when the blood level is not dramatically high. This is more concerning when symptoms are neurologic, such as new confusion, poor coordination, slurred speech, severe tremor, muscle jerks, unusual drowsiness, or falls. Chronic lithium toxicity can be subtle at first and may be mistaken for aging, medication sedation, infection, stroke, worsening mental health, or another neurologic condition.
A normal-looking result may be misleading if the sample was drawn late, if the level has already started falling after missed doses, or if lithium has accumulated in the nervous system. Symptoms should drive urgent evaluation when they are significant.
Low lithium with relapse symptoms
A low lithium level may reflect missed doses, poor absorption, late blood draw timing, increased clearance, or a dose that is too low for the person’s needs. If mood symptoms are returning, clinicians often review adherence, side effects that may be causing skipped doses, recent medication changes, and whether the level was drawn correctly.
It is usually unsafe to “catch up” by taking extra lithium. Dose changes should be planned because a rapid correction can overshoot, especially if kidney function changes or dehydration is present.
Rising lithium after illness or dehydration
Vomiting, diarrhea, fever, reduced fluid intake, heavy sweating, and acute infections can all raise lithium risk. A person may become dehydrated, and the kidneys may retain more lithium. This pattern can appear quickly, especially in older adults or people with reduced kidney reserve.
Clinicians often give lithium users specific “sick day” instructions, including when to hold lithium and when to seek blood tests. Those instructions should be individualized, because stopping lithium without guidance can also increase relapse risk.
Toxicity Symptoms and Urgent Thresholds
Lithium toxicity can be mild, moderate, or severe. Early symptoms may look like ordinary side effects, but progression can be dangerous. The risk rises as the level increases, especially around 1.5 mmol/L and above. Severe toxicity can require hospital care and, in some cases, dialysis.
Mild or early toxicity may include:
- Nausea, vomiting, or diarrhea
- Loss of appetite
- Fine tremor becoming more noticeable
- Tiredness or weakness
- Dizziness
- Thirst or increased urination
More concerning toxicity may include:
- Coarse tremor
- Poor coordination or unsteady walking
- Slurred speech
- Confusion or agitation
- Severe drowsiness
- Muscle twitching or jerking
- Blurred vision
- Ringing in the ears
- Falls
Severe toxicity may include seizures, coma, abnormal heart rhythm, severe dehydration, kidney failure, or marked changes in consciousness. These symptoms need emergency care.
| Situation | Why it matters | Typical action |
|---|---|---|
| Mild tremor but otherwise well | Can be a dose-related side effect or early warning sign | Contact the prescribing clinician for advice and possible level check |
| Vomiting or diarrhea while taking lithium | Fluid and sodium loss can raise lithium levels | Seek prompt medical advice; urgent tests may be needed |
| Confusion, poor balance, slurred speech, or falls | Neurologic toxicity can occur even near therapeutic levels | Urgent same-day assessment or emergency care |
| Known level around 1.5 mmol/L or higher | Toxicity risk is significantly increased | Urgent clinical review, especially with symptoms |
| Seizure, coma, severe weakness, or suspected overdose | Potentially life-threatening toxicity | Emergency services or emergency department care |
Toxicity is often divided into acute, chronic, and acute-on-chronic patterns. Acute toxicity happens after a large extra intake, such as overdose. Stomach symptoms may appear early, while neurologic symptoms may appear later as lithium moves into tissues. Chronic toxicity happens when lithium slowly accumulates during regular treatment, often because of kidney decline, dehydration, or an interaction. Acute-on-chronic toxicity happens when a person already taking lithium takes extra lithium or develops a sudden change that raises levels.
Chronic toxicity can be more dangerous than the number alone suggests because lithium may have had time to enter the brain and nervous system. This is why clinicians take neurologic symptoms seriously.
Medications, Fluid Balance, and Lab Pitfalls
Lithium levels can change after common medication changes. The most important interactions often involve kidney blood flow, sodium handling, or water balance.
Medicines that may raise lithium levels include:
- NSAIDs such as ibuprofen, naproxen, and some prescription anti-inflammatory drugs
- Thiazide diuretics such as hydrochlorothiazide and chlorthalidone
- ACE inhibitors such as lisinopril, enalapril, and ramipril
- ARBs such as losartan, valsartan, and candesartan
- Some loop diuretics, especially in people who become dehydrated or have kidney impairment
- Certain antibiotics or other medicines that affect kidney function indirectly
Not every person has the same response, and some medicines can be used with lithium when monitoring is planned carefully. The danger is starting, stopping, or changing these medicines without checking how lithium and kidney function respond.
Fluid and sodium changes can shift lithium levels
Lithium and sodium handling are closely linked. A sudden low-salt diet, heavy sweating, dehydration, vomiting, or diarrhea can cause the body to retain lithium. People taking lithium are often advised to keep fluid intake steady and avoid major sodium changes unless a clinician has given a specific plan.
This does not mean a person should eat a high-salt diet to “protect” against lithium toxicity. It means sudden changes can be risky. A stable, sensible intake is safer than large swings.
Blood draw and lab details can mislead interpretation
Several practical issues can make a lithium result confusing:
- The blood sample was not drawn 12 hours after the last dose.
- The person took the morning dose before the test.
- Doses were missed before the test.
- The dose was recently changed and steady state has not been reached.
- The formulation or brand changed, altering absorption.
- The lab used or received incomplete timing information.
- The sample was collected in the wrong tube type, such as a lithium heparin tube, which can falsely affect lithium measurement.
A surprising result should be checked against the story. If a person feels well, kidney tests are stable, and the only issue is a poorly timed sample, the clinician may repeat the level before changing the dose. If symptoms suggest toxicity, action should not wait for perfect lab conditions.
How Monitoring Usually Changes Over Time
Lithium monitoring is more frequent at the start of treatment and after dose changes. A common pattern is to check a level about 1 week after starting lithium or changing the dose, then repeat weekly or regularly until the level is stable. During the first year, lithium levels are often checked about every 3 months. Once stable, many people have lithium levels checked every 3 to 6 months, with kidney, thyroid, calcium, and electrolyte monitoring about every 6 months.
Monitoring is usually more frequent for people at higher risk, including those who:
- Are age 65 or older
- Have reduced or changing kidney function
- Take medicines that interact with lithium
- Have a lithium level of 0.8 mmol/L or higher
- Have poor symptom control
- Have inconsistent adherence
- Have major fluid or sodium intake changes
- Are pregnant or planning pregnancy
- Have high calcium or thyroid abnormalities
- Have recent illness, dehydration, vomiting, or diarrhea
Monitoring may also change after a hospitalization, medication switch, new diagnosis of chronic kidney disease, or abnormal urine findings.
Long-term kidney risk is managed by trends, not fear
Long-term lithium therapy can increase the risk of kidney problems in some people, but risk varies widely. Many people take lithium for years with stable kidney function. Others develop reduced urine concentrating ability, persistent thirst and urination, or gradual eGFR decline. The safest approach is regular monitoring and early response to trends.
A clinician may consider several options if kidney risk rises:
- Lowering the lithium target range
- Reducing the dose
- Changing once-daily versus divided dosing when appropriate
- Removing interacting medicines when possible
- Treating dehydration or blood pressure problems
- Checking urine albumin, urinalysis, or urine concentration
- Requesting nephrology input
- Discussing alternatives to lithium if risk outweighs benefit
Stopping lithium is a major psychiatric decision. Sudden discontinuation can increase the risk of relapse. When lithium is stopped, it is often tapered gradually unless toxicity or another urgent medical issue requires faster action.
Calcium and thyroid tests belong in the same monitoring plan
Lithium can affect more than kidney filtration. It can contribute to hypothyroidism and elevated calcium, often through parathyroid effects. This is why thyroid-stimulating hormone, sometimes free T4, and calcium are commonly included in long-term monitoring.
A person may notice fatigue, cold intolerance, constipation, weight gain, dry skin, depression-like symptoms, or slowed thinking with hypothyroidism. High calcium may cause thirst, frequent urination, constipation, abdominal discomfort, kidney stones, bone loss, or fatigue. These symptoms overlap with many conditions, so blood testing is important.
Questions to Discuss With Your Clinician
A lithium result is easier to use when the person taking lithium understands their own target, monitoring schedule, and warning symptoms. These questions can make follow-up visits more productive:
- What lithium range are we aiming for in my situation?
- Was my blood test drawn at the correct 12-hour trough time?
- Should I take my morning lithium dose before or after blood tests?
- What were my creatinine and eGFR compared with my previous results?
- Has my kidney function changed over more than one test?
- Do I need urine testing because of thirst, frequent urination, or falling eGFR?
- Which medicines should I avoid unless the lithium plan is adjusted?
- What should I do if I develop vomiting, diarrhea, fever, or dehydration?
- Which symptoms mean I should hold lithium and seek urgent advice?
- How often should I check lithium, kidney function, thyroid tests, and calcium?
- Would a lower lithium target still protect my mood while reducing side effects?
- Should a kidney specialist be involved?
People who take lithium should also keep an updated medication list and share it with every clinician, dentist, pharmacist, and urgent care provider they see. Over-the-counter medicines matter. NSAIDs are a common example because many people take them for pain, headaches, arthritis, or injuries without thinking of them as kidney-active medicines.
Lithium monitoring works best when the lab result, symptoms, and daily life changes are reviewed together. The safest result is not simply a number in range. It is a stable, correctly timed lithium level; stable kidney function; no concerning toxicity symptoms; no hidden interactions; and a clear plan for illness, dehydration, and follow-up testing.
References
- Lithium monitoring 2024 (Guidance)
- Bipolar disorder: assessment and management 2025 (Guideline)
- Shared Care Protocols (SCPs) 2025 (Shared Care Protocol)
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease 2024 (Guideline)
- What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium 2019 (Systematic Review)
- Lithium Poisoning 2017 (Review)
Disclaimer
Lithium dose changes should be made only with a prescribing clinician because stopping, increasing, or restarting lithium can cause serious harm. Seek urgent medical care for possible lithium toxicity symptoms such as confusion, severe tremor, poor coordination, repeated vomiting or diarrhea, severe drowsiness, seizures, or suspected overdose. This information is educational and does not replace individualized medical advice, diagnosis, or treatment.
